Imbruvica 140mg Capsule
Marketer
Janssen Pharmaceuticals
Salt Composition
Ibrutinib (140mg)
Overview Imbruvica 140mg Capsule
Ibrutinib 140mg capsules are indicated for managing mantle cell lymphoma and a type of blood cancer (chronic lymphocytic leukemia). This medication is also prescribed for patients with chronic lymphocytic leukemia who have undergone at least one prior treatment regimen. Dosage of Ibrutinib 140mg capsules should follow your physician's instructions. Treatment length depends on individual response. Regular blood tests to monitor blood cell counts are typically conducted during treatment, as this medicine can lower blood cell levels, potentially increasing infection risk. Common side effects include headache, diarrhea, and nausea. Report persistent or worsening side effects to your doctor. A patient support program, facilitated by Tata 1mg, offers assistance in India; inquire with your doctor or call (1800-102-1618) for further information.
Primary Ingredients of Imbruvica 140mg Capsule
There is no text provided to rephrase.
Uses of Imbruvica 140mg Capsule
Mantle cell lymphoma and chronic lymphocytic leukemia (a type of blood cancer)
Major Benefits of Imbruvica 140mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 140mg Imbruvica capsule can be administered with or without food, although consistent timing is recommended.
Common Side effects of Imbruvica 140mg Capsule:
- Headache
- Fever
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Nausea
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Rash
- Anemia (low number of red blood cells)
- Bruising
- Muscle spasm
- Hemorrhage
- Pneumonia
- Cough
- Dry eye
- High blood pressure
- Weight loss
- Urinary tract infection
- Peripheral edema
- Subdural hematoma
- Second primary malignancies
How to use Imbruvica 140mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Imbruvica 140mg Capsules can be administered with or without food, though consistent timing is recommended.
How Imbruvica 140mg Capsule works:
Ibrutinib 140mg capsules target Bruton's tyrosine kinase, inhibiting the activity of a faulty protein that drives cancer cell proliferation. This action suppresses or slows the growth of cancerous tissue.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imbruvica 140mg capsules may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Imbruvica 140mg capsules during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCAUTION
Use of Imbruvica 140mg capsules necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Imbruvica 140mg Capsules.
KidneyCAUTION
Patients with impaired kidney function should use Imbruvica 140mg capsules cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Imbruvica 140mg capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Imbruvica 140mg Capsule :
NA
Facts to Know About Imbruvica 140mg Capsule
| Label | Value |
|---|---|
| Chemical Classification | Diphenyl ether derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | BTK inhibitors |
3,018 People bought this recently
